Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
TRIOGEN Kaps 250 mg Ds 100 Stk
Drug
Triogen, Kapseln
Behandlung von Morbus Wilson bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen
07.99.0. – various
HAM – Human medicine
KAPS – Capsule
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
5/28/2020
5/27/2025
Dosage strength
Triogen 250 mg, Kapseln
Behandlung von Morbus Wilson bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen
01
Z – approved
Package
7680674310013
No information made available
A/R – Authorised / referenced
100 capsule(s)
001
Z – approved
Declaration
Component
250 mg trientini dihydrochloridum
silica colloidalis anhydrica
acidum stearicum
gelatina
aqua purificata
natrii laurilsulfas
0.0048 mg natrium
E 172 (flavum)
E 172 (rubrum)
E 171
lacca
alcohol butylicus
propylenglycolum
E 172 (nigrum)
kalii hydroxidum
acidum stearicum
gelatina
aqua purificata
natrii laurilsulfas
0.0048 mg natrium
E 172 (flavum)
E 172 (rubrum)
E 171
lacca
alcohol butylicus
propylenglycolum
E 172 (nigrum)
kalii hydroxidum
Spezialitätenliste***
SL
-
-
4470.40
None
Yes
10%
No
Authorisation holder
7601001403062
IDEOGEN AG
8807 Freienbach (SZ)
8807 Freienbach (SZ)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.